A Claims-Based Cohort Study on the Treatment Patterns of Japanese Patients with Type 2 Diabetes Mellitus and the Association of Early First Physician Visit with Time to Prescription of Oral Hypoglycemic Agents

被引:0
|
作者
Hirotaka Watada
Yasushi Kawakita
Keiko Tanaka
Akinori Oh
Nobuhiro Nishigaki
Tadashi Nakajima
Keita Fujikawa
Manabu Akazawa
机构
[1] Juntendo University,Department of Metabolism and Endocrinology, Graduate School of Medicine
[2] Takeda Pharmaceutical Company Limited,Department of Public Health and Epidemiology
[3] Meiji Pharmaceutical University,undefined
来源
Diabetes Therapy | 2021年 / 12卷
关键词
Type 2 diabetes mellitus; Claims-based cohort evidence; Diagnosis; Treatment course; Physician visit;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2035 / 2047
页数:12
相关论文
共 50 条
  • [1] A Claims-Based Cohort Study on the Treatment Patterns of Japanese Patients with Type 2 Diabetes Mellitus and the Association of Early First Physician Visit with Time to Prescription of Oral Hypoglycemic Agents
    Watada, Hirotaka
    Kawakita, Yasushi
    Tanaka, Keiko
    Oh, Akinori
    Nishigaki, Nobuhiro
    Nakajima, Tadashi
    Fujikawa, Keita
    Akazawa, Manabu
    DIABETES THERAPY, 2021, 12 (07) : 2035 - 2047
  • [2] Prescription of oral hypoglycemic agents for patients with type 2 diabetes mellitus: A retrospective cohort study using a Japanese hospital database
    Tanabe, Makito
    Motonaga, Ryoko
    Terawaki, Yuichi
    Nomiyama, Takashi
    Yanase, Toshihiko
    JOURNAL OF DIABETES INVESTIGATION, 2017, 8 (02) : 227 - 234
  • [3] Treatment patterns, persistence and adherence rates in patients with type 2 diabetes mellitus in Japan: a claims-based cohort study
    Nishimura, Rimei
    Kato, Haruka
    Kisanuki, Koichi
    Oh, Akinori
    Hiroi, Shinzo
    Onishi, Yoshie
    Guelfucci, Florent
    Shimasaki, Yukio
    BMJ OPEN, 2019, 9 (03):
  • [4] Association between use of oral hypoglycemic agents in Japanese patients with type 2 diabetes mellitus and risk of depression: A retrospective cohort study
    Akimoto, Hayato
    Tezuka, Kotoe
    Nishida, Yayoi
    Nakayama, Tomohiro
    Takahashi, Yasuo
    Asai, Satoshi
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2019, 7 (06):
  • [5] Impact of depression on utilization patterns of oral hypoglycemic agents in patients newly diagnosed with type 2 diabetes mellitus: A retrospective cohort analysis
    Kalsekar, ID
    Madhavan, SS
    Amonkar, MM
    Douglas, SM
    Makela, E
    Elswick, BLM
    Scott, V
    CLINICAL THERAPEUTICS, 2006, 28 (02) : 306 - 318
  • [6] PHARMACOECONOMIC EVALUATION OF THE ORAL HYPOGLYCEMIC AGENTS IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS PATIENTS IN THE RUSSIAN FEDERATION
    Ryazhenov, V. V.
    Emchenko, I., V
    VALUE IN HEALTH, 2013, 16 (07) : A440 - A440
  • [7] Neighborhood Social Environment and Patterns of Adherence to Oral Hypoglycemic Agents Among Patients With Type 2 Diabetes Mellitus
    McClintock, Heather F. de Vries
    Wiebe, Douglas J.
    O'Donnell, Alison J.
    Morales, Knashawn H.
    Small, Dylan S.
    Bogner, Hillary R.
    FAMILY & COMMUNITY HEALTH, 2015, 38 (02) : 169 - 179
  • [8] Characteristics of patients with type 2 diabetes mellitus grouped by 5 classes of oral hypoglycemic agents based on assessment of treatment satisfaction
    Ishii H.
    Oda E.
    Diabetology International, 2014, 5 (2) : 134 - 143
  • [9] Prescription patterns and therapeutic effects of second-line drugs in Japanese patients with type 2 diabetes mellitus: Analysis of claims data for metformin and dipeptidyl peptidase-4 inhibitors as the first-line hypoglycemic agents
    Nishimura, Rimei
    Takeshima, Tomomi
    Iwasaki, Kosuke
    Aoi, Sumiko
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (08) : 969 - 976
  • [10] Association of diabetes treatment with long-term glycemic patterns in patients with type 2 diabetes mellitus: A prospective cohort study
    Luo, Miyang
    Tan, Chuen Seng
    Lim, Wei Yen
    Chia, Kee Seng
    Tang, Wern Ee
    Tai, E. Shyong
    Venkataraman, Kavita
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2019, 35 (04)